Shares of Chinese clinical-stage novel drug developer Kintor Pharmaceutical Ltd rise as much as 7% to HK$16.48, their highest since June 8, on track to end two straight sessions of decline.
Kintor says the collaboration with Chinese e-commerce retailer JD can improve the company's capacity in commercial retail channels.

Contact our advisors through website chat